ALPRAZOLAM — all Canadian products
48 DINs
18 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is ALPRAZOLAM, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02243611 | APO-ALPRAZ | APOTEX INC | Tablet | Oral | ALPRAZOLAM 1 MG | Marketed | |
| 00865397 | APO-ALPRAZ | APOTEX INC | Tablet | Oral | ALPRAZOLAM 0.25 MG | Marketed | |
| 00865400 | APO-ALPRAZ | APOTEX INC | Tablet | Oral | ALPRAZOLAM 0.5 MG | Marketed | |
| 02243612 | APO-ALPRAZ TS | APOTEX INC | Tablet | Oral | ALPRAZOLAM 2 MG | Marketed | |
| 02397048 | JAMP ALPRAZOLAM | JAMP PHARMA CORPORATION | Tablet | Oral | ALPRAZOLAM 0.5 MG | Approved | |
| 02397021 | JAMP ALPRAZOLAM | JAMP PHARMA CORPORATION | Tablet | Oral | ALPRAZOLAM 0.25 MG | Approved | |
| 02397056 | JAMP ALPRAZOLAM | JAMP PHARMA CORPORATION | Tablet | Oral | ALPRAZOLAM 1 MG | Approved | |
| 02397064 | JAMP ALPRAZOLAM | JAMP PHARMA CORPORATION | Tablet | Oral | ALPRAZOLAM 2 MG | Approved | |
| 01908189 | PRO-ALPRAZOLAM | PRO DOC LIMITEE | Tablet | Oral | ALPRAZOLAM 0.25 MG | Marketed | |
| 02248706 | PRO-ALPRAZOLAM | PRO DOC LIMITEE | Tablet | Oral | ALPRAZOLAM 1 MG | Marketed | |
| 01908170 | PRO-ALPRAZOLAM | PRO DOC LIMITEE | Tablet | Oral | ALPRAZOLAM 0.5 MG | Marketed | |
| 02248707 | PRO-ALPRAZOLAM TS | PRO DOC LIMITEE | Tablet | Oral | ALPRAZOLAM 2 MG | Approved | |
| 01913492 | TEVA-ALPRAZOLAM | TEVA CANADA LIMITED | Tablet | Oral | ALPRAZOLAM 0.5 MG | Marketed | |
| 01913484 | TEVA-ALPRAZOLAM | TEVA CANADA LIMITED | Tablet | Oral | ALPRAZOLAM 0.25 MG | Marketed | |
| 00548359 | XANAX | BGP PHARMA ULC | Tablet | Oral | ALPRAZOLAM 0.25 MG | Marketed | |
| 00548367 | XANAX | BGP PHARMA ULC | Tablet | Oral | ALPRAZOLAM 0.5 MG | Marketed | |
| 00723770 | XANAX | BGP PHARMA ULC | Tablet | Oral | ALPRAZOLAM 1 MG | Marketed | |
| 00813958 | XANAX TS | BGP PHARMA ULC | Tablet | Oral | ALPRAZOLAM 2 MG | Marketed | |
| 02349205 | ALPRAZOLAM | SANIS HEALTH INC | Tablet | Oral | ALPRAZOLAM 0.50 MG | Cancelled Post Market | |
| 02434644 | ALPRAZOLAM | JAMP PHARMA CORPORATION | Tablet | Oral | ALPRAZOLAM 2 MG | Cancelled Pre Market | |
| 02434636 | ALPRAZOLAM | JAMP PHARMA CORPORATION | Tablet | Oral | ALPRAZOLAM 1 MG | Cancelled Pre Market | |
| 02434628 | ALPRAZOLAM | JAMP PHARMA CORPORATION | Tablet | Oral | ALPRAZOLAM 0.5 MG | Cancelled Pre Market | |
| 02434601 | ALPRAZOLAM | JAMP PHARMA CORPORATION | Tablet | Oral | ALPRAZOLAM 0.25 MG | Cancelled Pre Market | |
| 02349191 | ALPRAZOLAM | SANIS HEALTH INC | Tablet | Oral | ALPRAZOLAM 0.25 MG | Cancelled Post Market | |
| 02230074 | ALPRAZOLAM TABLETS 0.25 | PREMPHARM INC | Tablet | Oral | ALPRAZOLAM 0.25 MG | Cancelled Post Market | |
| 02230075 | ALPRAZOLAM TABLETS 0.5MG | PREMPHARM INC | Tablet | Oral | ALPRAZOLAM 0.5 MG | Cancelled Post Market | |
| 02400154 | JAMP-ALPRAZOLAM | JAMP PHARMA CORPORATION | Tablet | Oral | ALPRAZOLAM 2 MG | Cancelled Post Market | |
| 02400111 | JAMP-ALPRAZOLAM | JAMP PHARMA CORPORATION | Tablet | Oral | ALPRAZOLAM 0.25 MG | Cancelled Post Market | |
| 02400138 | JAMP-ALPRAZOLAM | JAMP PHARMA CORPORATION | Tablet | Oral | ALPRAZOLAM 0.5 MG | Cancelled Post Market | |
| 02400146 | JAMP-ALPRAZOLAM | JAMP PHARMA CORPORATION | Tablet | Oral | ALPRAZOLAM 1 MG | Cancelled Post Market | |
| 02229814 | MYLAN-ALPRAZOLAM | MYLAN PHARMACEUTICALS ULC | Tablet | Oral | ALPRAZOLAM 2 MG | Cancelled Post Market | |
| 02229813 | MYLAN-ALPRAZOLAM | MYLAN PHARMACEUTICALS ULC | Tablet | Oral | ALPRAZOLAM 1 MG | Cancelled Post Market | |
| 02137534 | MYLAN-ALPRAZOLAM | MYLAN PHARMACEUTICALS ULC | Tablet | Oral | ALPRAZOLAM 0.25 MG | Cancelled Post Market | |
| 02137542 | MYLAN-ALPRAZOLAM | MYLAN PHARMACEUTICALS ULC | Tablet | Oral | ALPRAZOLAM 0.5 MG | Cancelled Post Market | |
| 02417642 | NAT-ALPRAZOLAM | NATCO PHARMA (CANADA) INC | Tablet | Oral | ALPRAZOLAM 0.5 MG | Cancelled Post Market | |
| 02417669 | NAT-ALPRAZOLAM | NATCO PHARMA (CANADA) INC | Tablet | Oral | ALPRAZOLAM 2 MG | Cancelled Post Market | |
| 02417650 | NAT-ALPRAZOLAM | NATCO PHARMA (CANADA) INC | Tablet | Oral | ALPRAZOLAM 1 MG | Cancelled Post Market | |
| 02417634 | NAT-ALPRAZOLAM | NATCO PHARMA (CANADA) INC | Tablet | Oral | ALPRAZOLAM 0.25 MG | Cancelled Post Market | |
| 02346990 | NTP-ALPRAZOLAM | TEVA CANADA LIMITED | Tablet | Oral | ALPRAZOLAM 0.25 MG | Cancelled Pre Market | |
| 02347008 | NTP-ALPRAZOLAM | TEVA CANADA LIMITED | Tablet | Oral | ALPRAZOLAM 0.5 MG | Cancelled Pre Market | |
| 00677477 | RATIO-ALPRAZOLAM | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | Oral | ALPRAZOLAM 0.5 MG | Cancelled Post Market | |
| 00677485 | RATIO-ALPRAZOLAM | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | Oral | ALPRAZOLAM 0.25 MG | Cancelled Post Market | |
| 02404893 | RIVA-ALPRAZOLAM | LABORATOIRE RIVA INC. | Tablet | Oral | ALPRAZOLAM 1 MG | Cancelled Post Market | |
| 02404885 | RIVA-ALPRAZOLAM | LABORATOIRE RIVA INC. | Tablet | Oral | ALPRAZOLAM 0.5 MG | Cancelled Post Market | |
| 02404877 | RIVA-ALPRAZOLAM | LABORATOIRE RIVA INC. | Tablet | Oral | ALPRAZOLAM 0.25 MG | Cancelled Post Market | |
| 02404907 | RIVA-ALPRAZOLAM | LABORATOIRE RIVA INC. | Tablet | Oral | ALPRAZOLAM 2 MG | Cancelled Post Market | |
| 02242107 | RIVA-ALPRAZOLAM 0.25 MG | LABORATOIRE RIVA INC. | Tablet | Oral | ALPRAZOLAM 0.25 MG | Cancelled Pre Market | |
| 02242108 | RIVA-ALPRAZOLAM 0.5 MG | LABORATOIRE RIVA INC. | Tablet | Oral | ALPRAZOLAM 0.5 MG | Cancelled Pre Market |
Browse other molecules: